Thanks to support from companies in the health care industry, the 2024 AANP National Conference is able to offer complimentary access to non-CE Product Theaters (PTs) for registered conference attendees. PTs are educational presentations, which may be branded and are usually sponsored using marketing funds from health care industry companies.
Regulations and Restrictions
Some state regulations require industry to track and report the value of “gifts” to health care providers from industry marketing. The report must contain the recipient’s name and contact information. Since product theater industry sponsors must declare the value of each meal provided to attendees as a “gift,” each product theater attendee is providing permission for AANP to release their contact information (including name, mailing address, phone number, email address and other information, as requested) to the event sponsor and/or their organizing company for the purpose of meeting the various state regulations or government reporting requirements and sending attendees related event product updates. In some states, the total value of “gifts” a provider may receive annually is so low that sponsors of a particular product theater may elect to not provide access to attendees from certain states. There are also restrictions in some employment settings for some states.
AANP will assist in notifying registered conference attendees from the states or employment settings that are not eligible to attend PTs if information regarding restrictions is provided by the sponsor. The sponsor's signage will also be featured near the event entrance, indicating any states and employment settings restricted from attending the industry sponsored non-CE PT event.
AANP Industry Non-CE Disclaimer Statement
The opportunity to attend any industry non-CE event is available only to registered AANP conference attendees. The product theater event and its program information at this AANP conference is not an AANP product endorsement. AANP has not reviewed the product theater content or slides as this is a non-CE event.
Registration and Admission
Due to their educational focus, attendance is limited. Restrictions apply. PTs are only open to registered conference attendees. Registration and admission will occur at the entrance of each scheduled event on a first come, first served basis. You must have your conference name badge with you to be scanned for admission. There will be no pre-registration.
24.2.061
Navigating the Post-Pandemic Era as a Healthcare Provide
24.2.063
Progressive Pulmonary Fibrosis (PPF): Diagnosis and Patient Management
24.2.064
Closing the CRC Screening Gaps: Integrating Screening Protocols, Improving Participation
24.2.137 Navigating Uncomplicated UTIs: Empowering NPs to Address Treatment Failure
24.2.138 Expert Clinical Discussion – LIVE patient assessment to showcase anatomy considerations, treatment insights, and HCP/Patient Dialogue
24.2.139 Early Use of CGM in Type 2 Diabetes: Late-Breaking Trials on CGM-Directed Glycemic Management, Patient Safety, and Resource Utilization Across the Spectrum of Diabetes Care
24.3.001 Xolair: A Therapeutic Option For IgE-Mediated Food Allergies
24.3.002 PrEP today. Data discussions on an HIV-1 PrEP option
24.3.003 VEOZAH™ (fezolinetant) For the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause
24.3.076 Redefining the Treatment of Insomnia
24.3.077 Reframing Rescue Therapy to Help Prevent Asthma Exacerbations
24.3.078 Continuing Impact of COVID-19: Updates to Burden of Disease and Information on a Vaccine Option from BioNTech and Pfize24 3 079
24.4.002 INHIBITING IL-4 AND IL-13 SIGNALING ACROSS ASTHMA, AD, AND EOE IN PEDIATRICS
24.4.003 The Power of the Pod. Simplifying Management of Type 2 Diabetes with Omnipod DASH
24.4.060 HIV Prevention as Primary Care
24.4.061 Keys to Starting and Optimizing CGM Workflow with FreeStyle Libre Systems
24.4.062 Respiratory Syncytial Virus (RSV) Disease Burden and Option for Vaccine
24.4.063 Tardive Dyskinesia Is Personal: Go Beyond the Data with a Real Patient Story
24.4.118 NP Quiz Time: Test Your Knowledge on Treatments for Gastroesophageal Reflux Disease
24.4.119 Discover what Mounjaro can offer adults with type 2 diabetes
24.4.120 Prescribe More Time: Potential to Delay the Onset of Stage 3 T1D With TZIELD
24.5.001 Stratifying Fracture Risk to Guide Treatment Selection in Postmenopausal Osteoporosis
Understanding the Burden and Treatment of Hyperkalemia in Chronic Kidney Disease
24.5.059 Discover ZepboundTM (tirzepatide) injection at 2024 AANP National Conference
24.5.060 Navigating the Complexity of Obesity
24.5.061 DISCOVER THE IMPACT OF GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment
24.5.062 The FLU Ends With U: The Nurse Practitioner’s Impact
24.5.063 Treating MDD: A Rapid-Acting Oral Antidepressant with Multimodal Activity